Geffen Residence & Renewal Ltd (TLV:GEFR)
79.20
-0.70 (-0.88%)
Jan 29, 2026, 5:24 PM IDT
TLV:GEFR Revenue
Geffen Residence & Renewal had revenue of 20.00K ILS in the quarter ending September 30, 2025, a decrease of -42.86%. This brings the company's revenue in the last twelve months to 84.00K, down -40.85% year-over-year. In the year 2024, Geffen Residence & Renewal had annual revenue of 131.00K, down -7.75%.
Revenue (ttm)
84.00K
Revenue Growth
-40.85%
P/S Ratio
3,080.34
Revenue / Employee
4.00K
Employees
21
Market Cap
258.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 131.00K | -11.00K | -7.75% |
| Dec 31, 2023 | 142.00K | 82.00K | 136.67% |
| Dec 31, 2022 | 60.00K | -598.00K | -90.88% |
| Dec 31, 2021 | 658.00K | -2.01M | -75.33% |
| Dec 31, 2020 | 2.67M | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioLineRx | 42.17M |
| Evogene | 26.54M |
| XTL Biopharmaceuticals | 3.26M |
| Can-Fite BioPharma | 1.89M |
| Clal Biotechnology Industries | 91.00K |
| BioLight Life Sciences | 21.00K |